Evolution of the Average Target: Alcon Inc.

Data source: Alcon Inc.(ALC)

Evolution of the Target Price: Alcon Inc.

Data source: Alcon Inc.(ALC)

Changes in Analyst Recommendations: Alcon Inc.

Data source: Alcon Inc.(ALC)
db143ddaec9090411a77c8cc03.GU2ct3jH8SH8bLCw9CX1AR-9-GPfXOjYFScd3-dFBNQ.Rjro4RCXnm2KNPP6o1CjMyv1sQiYOpG1IxZ6rsp9NJ1zffblT_ecdaU52w~46e6c9bb1ad74dfd8e45bfdf79abbcb0
02/10 AlphaValue/Baader Europe Upgrades Alcon to Buy MT
24/09 Bernstein: Alcon a 'Top Long-term Compounder' Amid 'Transitory' Near-term Pressures MT
11/09 Berenberg Sees Alcon as 'Best Way' into Ophthalmology Market Exposure; Buy Rating Affirmed MT
17/08 Deutsche Bank raises TP for Alcon, but shares down Zonebourse
13/08 BNP Paribas Downgrades Alcon to Neutral, Cuts PT MT
13/08 Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 MT
11/08 Alcon: Q2 story: Innovation is being well received by the end market Alphavalue
25/05 Baptista Research Upgrades Alcon to Buy Rating MT
12/05 Swiss Market Index Closes Higher; SoftwareOne Shares Jump MT
08/05 Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised MT
07/05 Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating MT
06/05 Alcon: Results weren't bad; today's correction is a buying opportunity Alphavalue
06/05 Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses MT
06/05 Swiss stocks - Factors to watch on May 6 RE
05/05 Alcon: Investment case hinges on profitability expansion Alphavalue
21/04 RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained MT
19/03 AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT MT
16/03 Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In MT
10/03 Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 MT
06/03 Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound MT
04/03 Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised MT
27/02 Equita SIM Upgrades Alcon to Buy, Raises PT MT
26/02 Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating MT
26/02 Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88 MT
26/02 Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+23.68%
+21.36%
+33.54%
+62.89%
+19.48%
+24.9%
+10.67%
+35.29%
+11.39%
Average +27.02%
Weighted average by Cap. +27.95%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
63.72USD
Average target price
91.32USD
Spread / Average Target
+43.31%
High Price Target
105.27USD
Spread / Highest target
+65.22%
Low Price Target
59.24USD
Spread / Lowest Target
-7.02%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
-